Article Text


Changing pattern of paediatric inflammatory bowel disease in northern Stockholm 1990–2001
  1. H Hildebrand,
  2. Y Finkel,
  3. L Grahnquist,
  4. J Lindholm,
  5. A Ekbom,
  6. J Askling
  1. Department of Women and Child Health, Astrid Lindgren Children’s Hospital, Stockholm, Sweden
  1. Correspondence to:
    Dr H Hildebrand, Astrid Lindgren Children’s Hospital, SE 171 76 Stockholm, Sweden;


Background: An increased incidence of paediatric Crohn’s disease was reported recently by our group.

Aims: To assess the incidence and characteristics of inflammatory bowel disease (IBD) in northern Stockholm between 1990 and 2001.

Methods: All records of individuals 0–15 years of age with suspected IBD in the population based catchment area of 180 000 individuals were scrutinised using defined diagnostic criteria. Patient files were searched for relatives with IBD, and for concomitant autoimmune diseases.

Results: A total of 152 children were diagnosed with IBD, corresponding to an overall incidence (per 100 000) of IBD of 7.4. The incidence of Crohn’s disease (CD) was 4.9, ulcerative colitis (UC) 2.2, and indeterminate colitis 0.2. Between 1990 and 2001, there was a marked increase in the incidence of CD while the incidence of UC was almost unchanged, leading to a net increase in the overall occurrence of IBD. There was a male dominance of CD. Fourteen per cent and 11% of patients with CD and UC, respectively, had a first or second degree relative with IBD. Eighteen per cent and 10% of patients with CD and UC, respectively, had a concomitant autoimmune disease. Ten patients with CD (10%) underwent surgery.

Conclusions: The incidence of CD has increased in northern Stockholm. The current incidence is higher than that reported from other areas. Our results suggest a shift in presentation and diagnosis from UC towards CD, but also a net increase in IBD. Concomitant autoimmune disorders and family history are common in paediatric IBD.

Statistics from

We recently reported a markedly increased number of cases of paediatric Crohn’s disease (CD) in northern Stockholm, Sweden.1 In the present study, we present new data on time trends, with emphasis on classification of inflammatory bowel disease (IBD), familial IBD, autoimmune comorbidity, and surgical treatment.


This prospective study comprised all residents less than 16 years of age in northern Stockholm County (180 000 individuals). Between 1990 and 2001, all children with suspected IBD were referred to our department for evaluation following an agreement with all doctors in the catchment area. All children were examined with colonoscopy, and most (78%) with upper gastrointestinal endoscopy, including biopsies for histology. The small intestine was examined by either x ray or scintigraphy. For the diagnosis of ulcerative colitis (UC), CD, and indeterminate colitis (IC), strict criteria were used2,3 and IC was only used when a distinct diagnosis of UC or CD could not be established. Trends or differences in incidence were evaluated using Poisson regression models, including calendar period of diagnosis, sex, and age.


During 1990–2001, 152 children and adolescents were diagnosed with IBD (102 with CD, 45 with UC, and five with IC). Mean age at diagnosis of CD was 11.1 years (minimun−maximum 2.5–15.9), mean age at diagnosis of UC was 12.8 years (6.5–15.8), and mean age at diagnosis of IC was 8.3 years (0.3–10.6).

In 21 children (14%), the initial IBD diagnosis was changed; 15 children had their diagnosis changed from UC to CD, five from IC to CD, and one from IC to UC. The new diagnosis was established after repeated colonoscopies in 19 children, at surgery in one, and after upper gastrointestinal endoscopy in one.

In CD, 56 children (55%) had disease confined to the large intestine, 26 children (25%) had both small and large bowel involvement, and 17 children (17%) had involvement of the upper gastrointestinal tract (oesophagus, stomach, and/or duodenum) in combination with the small or large intestine (table 1). Two children (2%) had disease confined to the small intestine. One child had only oral localisation. Fifteen children (15%) with CD had fistulae. In UC, 33 children (73%) had total colitis and 12 children (27%) had left sided colitis.

Table 1

Localisation of inflammation in 102 patients with Crohn’s disease

The overall incidence (per 100 000) of IBD was 7.4 (95% confidence interval 6.2–8.6). The overall incidence of CD was 4.9 (4.0–6.0), the incidence of UC was 2.2 (1.6–2.9), and the incidence of IC was 0.2 (0.1–0.6). During the study period, the incidence of IBD increased (p = 0.0014) (table 2). The incidence of CD increased from 1.7 (0.7–3.3) in 1990–1992 to 3.5 (2.1–5.5) in 1993–1995, to 5.6 (3.8–8.1) in 1996–1998, and to 8.4 (6.2–11.3) in 1999–2001 (p for trend 1990–2001 <0.0001, the positive trend was present both among individuals aged 5–9 years and 10–15 years, respectively). Apart from a non-significantly higher point estimate during 1990–1992, the incidence of UC remained stable throughout the study period. The ratio of CD to UC increased from 0.5 in 1990–1992, to 2.0 in 1993–1995, 3.0 in 1996–1998, and to 4.6 in 1999–2001. Males had a significantly higher incidence of IBD than females (p = 0.0059) due to a near doubled and significantly higher incidence of CD (p = 0.0144).

Table 2

Incidence (with 95% confidence intervals) of inflammatory bowel disease (IBD) in children and adolescents 0–15 years of age in northern Stockholm 1990–2001

Fourteen children with CD (14%) had at least one first or second degree relative with IBD (12 CD, five UC). Five children with UC (11%) had at least one first or second degree relative with IBD (three CD, four UC). Concomitant autoimmune diseases (primary sclerosing cholangitis, chronic polyarthritis, coeliac disease, pulmonary fibrosis, pancreatitis, systemic lupus erythematosus, and thyroiditis) were more common in CD (18%) than in UC (10%). Surgical treatment was performed in 10 children with CD. No child with UC or IC underwent surgery.


The increasing incidence of CD, and the stable incidence of UC, corroborates earlier reports from the UK.4–6 Our incidence of CD is 50% higher (but that of UC is similar) than that of the hitherto largest (cross sectional) study.7 The predominance of CD over UC is in agreement with (non-population based) studies from North America8–10 but in contrast with earlier Scandinavian studies.2,3,11–13 The difference may however be explained by temporal differences as our incidences during the same calendar period as that of the most recent Swedish study are similar.3 The higher incidence among males is similar to that of previous paediatric,7,10 but not that of adult studies.14 In contrast with most previous reports4,15 —except for two recent studies10,16 —colonic CD or colon combined with upper gastrointestinal tract involvement was common (80%) whereas exclusive small bowel CD was not.

In our study, the diagnostic criteria remained the same during the study period but the number of endoscopies per patient and the proportion of upper gastrointestinal endoscopies increased over time. This may have led to a change in the distribution of subtypes of IBD.2,3,12,17,18 Our incidence of IC is the lowest reported, most likely as a consequence of repeated endoscopic investigations eventually establishing a diagnosis of (mostly) CD. Abnormalities compatible with CD found at upper gastrointestinal endoscopy affected the final diagnosis in only two patients; most children with CD had their diagnosis based on colonoscopy. Analysis of the initial versus the final diagnosis of IBD in our study revealed that reclassification contributed to an overall 24% increase in the incidence of CD (a doubling of the incidence before 1995, and a marginal effect thereafter), but served as an incomplete explanation for the time trends, sex difference, and dominance of CD over UC. However, this study demonstrates a net increase in the incidence of IBD which cannot be attributed to shifts in the incidences of subgroups.

Other autoimmune diseases were common, especially in comparison with values in adult IBD.19 Surgical treatment was comparatively rare,2–4,13 possibly because of early diagnosis and rapid institution of therapy.20–24

Our study has confirmed and characterised a marked increase in the incidence of CD, indicated the importance of repeated re-evaluation, but also the limited influence of changes in classification of IBD on temporal trends. Of special interest were the high proportion of colonic CD and the high prevalence of autoimmune conditions in paediatric IBD, both of which warrant further investigation.


View Abstract

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.